SCHEMBL5570362

SCHEMBL5570362

CN1Sc2cc3c(cc2CC1=O)CCCC3

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CDC25B P30305 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5565920 0.75 MEN1 (0.39) GAA
SCHEMBL5568649 0.71 CES1 (0.37)
SCHEMBL7002280 0.64 GAA (0.34) GAASMN1; SMN2CDC25B
SCHEMBL7001476 0.64 GAA (0.34) GAASMN1; SMN2CDC25B
SCHEMBL5565090 0.63 BRD4 (0.31)
SCHEMBL1760720 0.62 TSHR (0.50) GAACDC25B
SCHEMBL28303303 0.60 CDC25B (0.43) GAACDC25B
SCHEMBL25202453 0.59 CDC25B (0.48) GAACDC25B
SCHEMBL30635627 0.59 CDC25B (0.48) GAACDC25B
SCHEMBL10373066 0.59 BRD4 (0.46) GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1750719-A2 TREATMENT OF DISEASES ASSOCIATED WITH ALTERED LEVEL OF AMYLOID BETA PEPTIDES Boehringer Ingelheim International GmbH (DE) 2007-02-14 EP disclosed
WO-2005110422-A2 TREATMENT OF DISEASES ASSOCIATED WITH ALTERED LEVEL OF AMYLOID BETA PEPTIDES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-24 WO disclosed